The Trauma INtramuscular Tranexamic Acid Clinical Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 17, 2019

Primary Completion Date

February 12, 2020

Study Completion Date

February 12, 2020

Conditions
Traumatic Haemorrhage
Interventions
DRUG

Tranexamic 1 gram

To be administered intramuscularly (2 injections)

Trial Locations (2)

E1 1FR

The Royal London Hospital, London

SW17 0QT

St George's Hospital, London

All Listed Sponsors
collaborator

Barts & The London NHS Trust

OTHER

collaborator

St George's University Hospitals NHS Foundation Trust

OTHER

collaborator

University of Versailles

OTHER

collaborator

JP Moulton Charitable Foundation

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT03875937 - The Trauma INtramuscular Tranexamic Acid Clinical Trial | Biotech Hunter | Biotech Hunter